TNPSC Thervupettagam

Pretomanid Tablets – Treating Drug Resistant TB

August 17 , 2019 1929 days 1813 0
  • The United States has approved the use of Pretomanid Tablets to treat an extremely drug-resistant strain of tuberculosis.
  • Pretomanid when used in combination with antibiotics bedaquiline and linezolid cured 89% of 107 patients with extensively drug-resistant TB after 6 months.
  • The above three drugs together called BPaL regimen.
  • Because of the new treatment, TB patients who were supposed to take 30 pills a day can now take only 5 pills a day.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories